Associated Papers
EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.
Li Z et al.
Bmc Pulmonary Medicine, 2022
36123678 (PubMed )
Supplement: 12890_2022_2161_MOESM2_ESM.xlsx › OAK_POPLAR_btmb_variants
Circulating versus cellular tumor DNA for the detection of BTK resistant CLL clones.
Trummer A et al.
Leukemia Research Reports, 2022
Select a paper to view details